MedTrace Logo

Virtual Rehabilitation for Cancer Survivors

NCT05898789 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 388

Last updated 2026-02-25

No results posted yet for this study

Summary

Pragmatic hybrid type 1 effectiveness-implementation (E-I) trial of a virtual cancer rehabilitation program: The study team will conduct a multi-center hybrid type I effectiveness-implementation study to examine the clinical effectiveness and implementation potential of an 8-week multidimensional virtual cancer rehabilitation intervention (CaRE@Home) for cancer survivors with identified cancer-related impairments on level of overall disability (primary outcome) and patient reported physical and social functioning, anxiety, work status, quality of life, and physiologic changes (secondary outcomes). The study team will conduct a multi-centre pragmatic randomized controlled trial (RCT) (Vancouver, Toronto, Saint John and St. John's) to evaluate effectiveness and using the CIFR, the study team will identify potential factors that may affect successful implementation and integration of CaRE@Home in different cancer settings.

Conditions

  • Breast Cancer, Stage 0
  • Colorectal Cancer Stage I
  • Head and Neck Cancer Stage I
  • Lymphoma
  • Breast Cancer Stage I
  • Breast Cancer Stage II
  • Breast Cancer Stage III
  • Colorectal Cancer Stage II
  • Colorectal Cancer Stage III
  • Head and Neck Cancer Stage II
  • Head and Neck Cancer Stage III
  • Lymphoproliferative Disorders

Interventions

BEHAVIORAL

CaRE@Home intervention

participants randomized to the intervention arm will complete a virtual 8 week exercise and education program.

Sponsors & Collaborators

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Jennifer Jones, PhD · UHN Princess Margaret Cancer Centre

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-07
Primary Completion
2026-06-30
Completion
2026-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05898789 on ClinicalTrials.gov